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Abstract From 1994 to 2009, the incidence of invasive
serotype 19A pneumococci isolated from adults in Barcelona
and San Sebastian almost doubled every 4 years. Genotyping
of the 167 invasive isolates studied showed serotype 19A to
be highly heterogeneous, with 35 different sequence types
(STs) and a different clonal structure in each region and time
period. Multiresistance, defined as non-susceptibility to three
or more antimicrobials, was found in 86 (51.5%) isolates. The
most frequent STwas the multidrug-resistant ST276 (n=28),
which is a single-locus variant of the Denmark14-ST230
global clone. The ST276 clone, only present in San
Sebastian before 2001, was successfully disseminated from
2002 in both cities and was the main contributor to the
overall increase of serotype 19A infections.
Introduction
Infections caused by Streptococcus pneumoniae are among
the first causes of morbidity and mortality due to an
infectious disease worldwide. After the commercialization
of the 7-valent pneumococcal protein conjugate vaccine
(PCV7) in 2000, invasive pneumococcal disease (IPD)
caused by vaccine serotypes substantially decreased, while
non-vaccine serotypes increased [1, 2]. In the last few
years, serotype 19A pneumococci as a cause of IPD have
increased worldwide. This increase has been observed in
countries with and without the introduction of the PCV7 in
children [3–5]. Moreover, the increase of multidrug-
resistant pneumococci serotype 19A, such as ST320 in the
USA, Europe, and Asia, and ST276 in Europe, is especially
worrisome [4, 6–13].
The aim of this study was to analyze the evolution of
invasive serotype 19A infections in the adult populations of
two Spanish cities in the 16 years before the introduction of
the new 10-valent (PCV10) and 13-valent (PCV13)
conjugate vaccines, which also cover serotype 19A. The
possible effect of the introduction of the PCV7 in June
2001 in Spain was also analyzed.
Materials and methods
This study was simultaneously performed in two cities: San
Sebastian, in the north of Spain, and Barcelona, in the
northeast of Spain. The two cities are 571 km apart.
The study included all S. pneumoniae isolates causing
IPD obtained from patients aged ≥15 years old attending
Hospital Donostia and Hospital Universitari de Bellvitge
between January 1994 and December 2009. IPD was
considered when a pneumococcus was isolated from a
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sterile location. There were no significant changes in the
diagnostic techniques or in the population attended during
the study period, except for the period 1994–1997. In this
period, Hospital Donostia attended one-third fewer adult
patients than in later periods. The incidence rates of invasive
serotype 19A infections were calculated using the population
attended by each hospital per year as the denominator. The
identification of isolates and antimicrobial susceptibility
methods were performed as previously reported [6, 14].
Isolates were serotyped by the Quellung reaction and by
polymerase chain reaction (PCR) [15]. The broth micro-
dilution technique was used to study the antimicrobial
susceptibility of the isolates according to the guidelines and
criteria of the Clinical and Laboratory Standards Institute
(CLSI) [16]. The non-susceptibility criterion included iso-
lates that had a minimum inhibitory concentration (MIC)
above the value indicated for the susceptible breakpoints.
The genotyping of all serotype 19A isolates was
performed using pulsed-field gel electrophoresis (PFGE).
Multilocus sequence typing (MLST) was performed
according to the methodology described on the pneumo-
coccal MLST web site (http://www.mlst.net). Overall, 106/
167 isolates were studied by MLST, which included at least
one representative isolate of each different PFGE type.
eBURST groups were defined using the most stringent
(conservative) definition of eBURSTv3: all members
assigned to the same group share identical alleles at precisely
6 of the 7 loci, with at least one other member of the group.
For clonal complexes (CCs), a cut-off point of 5 identical loci
to the predicted founder of its eBURST group was used.
Results
Between 1994 and 2009, S. pneumoniae serotype 19A
caused 167/ 2,577 (6.5%) IPD episodes in people >14
years of age: 80/975 (8.2%) at Hospital Donostia and 87/
1,602 (5.4%) at Hospital Bellvitge. Table 1 shows the
results analyzed in the four 4-year periods and by age
group (15–39, 40–64, and >64 years old). The highest
incidence of IPD, as well as the greatest increase of IPD
rates, was observed in the elderly. The incidence in
younger adults (15–39 years old) was low and nearly the
same in each 4-year period. When the first and last periods
were compared, the overall incidence of IPD due to
serotype 19A showed a five-fold increase. Indeed, in the
2006–2009 period, serotype 19A accounted for 84/812
(10.3%) invasive isolates from adults; moreover, this
serotype accounted for 52/379 (13.7%) pneumococci
isolated from adults aged >65 years, a population group
that could be included in vaccination programs with the
new PCV10 and PCV13 vaccines.
The 167 invasive serotype 19A isolates were grouped
into 35 different sequence types (STs) and 14 CCs, with
three CC-related STs, three STs without defined CCs but
belonging to a known eBURST group, and three singletons
(Table 2). The most frequent CCs were CC230 and CC199.
These two CCs, together with ST1201 and ST202,
represented 69.5% of all isolates.
Invasive serotype 19A infections increased mainly from
2002, associated with the spread of preexisting clones
(ST276, ST1201, and ST202) and the “local” appearance of
new clones (ST199 and ST193 in San Sebastian, and ST81
and ST2013 in Barcelona).
Overall, 60/167 serotype 19A isolates (35.9%) were
susceptible to all of the antibiotics tested, but the
antimicrobial susceptibility was higher in San Sebastian
(41/80; 51.2%) than in Barcelona (19/87; 21.8%). Multi-
resistance, defined as non-susceptibility to three or more
antimicrobials, was found in 86 (51.5%) isolates.
Most penicillin non-susceptible isolates (46/61, 75.4%)
showed a penicillin MIC of 0.12–0.5 μg/mL. The only
clone showing 100% penicillin MIC ≥2 μg/mL was ST320
(n=6). Two ST276 isolates and seven ST81 isolates also
showed penicillin MICs≥2 μg/mL. Twenty-five isolates (14
ST276, three ST320, and eight ST81) had a cefotaxime
MIC=1 μg/mL, and three isolates (ST320) had a cefotax-
ime MIC=2 μg/mL.
Table 1 Number and incidence
of invasive serotype 19A Strep-
tococcus pneumoniae infections
in adults from San Sebastian and
Barcelona, Spain
aAnnual incidence per million
population
bThe 7-valent pneumococcal con-
jugated vaccine (PCV7) was
introduced in Spain in June 2001
Period 15–39 years old 40–64 years old >64 years old Total
No. Incidencea No. Incidence No. Incidence No. Incidence
1994–1997 7 4.1 2 1.6 6 10.7 15 4.2
1998–2001 6 3.5 7 5.2 9 14.4 22 6.0
2002–2005 6 3.4 17 11.8 23 33.7 46 11.8
2006–2009 7 4.0 25 16.0 52 71.1 84 20.9
Pre-PCV7 (1994–2001)b 13 3.8 9 3.5 15 12.7 37 5.1
Post-PCV7 (2002–2009) 13 3.4 38 11.3 75 32.5 130 11.6
Total 26 3.7 51 9.1 90 34.6 167 11.0
Eur J Clin Microbiol Infect Dis
Table 2 Temporal distribution of Streptococcus pneumoniae serotype 19A genotypes causing invasive disease in the adult population in San
Sebastian and Barcelona, Spain, 1994–2009
Clonal complex (CC) No. ST No. Susceptibility patterna Period
1994–1997 1998–2001 2002–2005 2006–2009
Common CCs (San Sebastian and Barcelona)
CC230 37 276 28 PECmTS (16), PECmT (9), PECm (1),
ECmTS (1), PTS (1)
– 2 11 15
2013 9 PTS (8), PECmTS (1) – – 1 8
CC230-relatedb 1 4010 1 PTS – – – 1
CC199 29 199 22 susceptible (22) – 3 7 12
416 3 susceptible (3) – – 2 1
274 1 susceptible – – – 1
450 1 susceptible – – 1 –
645 1 susceptible – – – 1
667 1 susceptible – – 1 –
CC320 6 320 6 PECmTS (6) – – – 6
CC320-relatedb 23 202 19 ECmTS (8), TS (6), E (2), P (1), ECmS (1),
susceptible (1)
7 7 4 1
3259 4 ECm (2), susceptible (2) 1 – 3 –
ST1201c 27 1201 27 susceptible (22), ECmT (4), Ci (1) 1 1 6 19
CC81 10 81 9 PECmTS (6), PECmTS (2), PECmT (1) 1 3 3 2
3604 1 PTSCi 1 – – –
CC193 9 193 7 ECmT (6), T (1) – 1 – 6
2110 1 ECmT – – – 1
6156 1 susceptible – – – 1
CC63 6 63 6 ECmT (4), TS (1), PECmT (1) – 4 1 1
CC6158 2 994 1 susceptible – – – 1
6158 1 susceptible – – – 1
Local CC (Barcelona)
CC433 4 433 4 susceptible (4) – – 3 1
CC156 2 156 1 PECmT – – 1 –
157 1 PES – – – 1
CC88 1 88 1 PTS 1 – – –
CC344 1 344 1 PECmTS – – 1 –
ST4000c 1 4000 1 PS – – – 1
Singleton 1 3995 1 TSCi 1 – – –
Local CC (San Sebastian)
CC53 1 62 1 PS 1 – – –
CC53-relatedb 1 3019 1 ES – – – 1
CC218 1 944 1 susceptible – – – 1
ST361c 1 361 1 PECmT – – – 1
CC2468 1 2468 1 susceptible – – 1 –
Singleton 1 6154 1 S 1 – – –
Singleton 1 6155 1 ECmT – 1 – –
Total 167 167 15 22 46 84
a In parentheses are shown the number of isolates of each susceptibility pattern. Susceptible: susceptible to all of the antimicrobials tested: E,
erythromycin; Cm, clindamycin; T, tetracycline; S, trimethoprim–sulfamethoxazole; P, penicillin; Ci, ciprofloxacin
b CC-related: ST having four alleles identical to the predicted founder of the clonal complex
c ST without defined CC but belonging to a known eBURST group
Eur J Clin Microbiol Infect Dis
Discussion
Since the introduction of the PCV7, there have been many
reports initially from the USA [3] and later from other
countries, alerting about the increase of S. pneumoniae
serotype 19A invasive infections [4, 9]. The attribution of
this increase to the introduction of the PCV7 is controver-
sial, as, in some places where the vaccine had not been
introduced, similar increases in the rates of serotype 19A
IPD were reported [4, 5]. We observed an increase in
invasive serotype 19A infections throughout the study
period in the adult population in both Barcelona and San
Sebastian. The increasing trend of serotype 19A invasive
infections was mainly due to the increase in the population
aged over 65 years, especially since 2001, the year of the
introduction in Spain of the PCV7. The increase of serotype
19A IPD in the elderly has also been observed in other
countries, such as the USA [8].
There are five major CCs associated with serotype 19A
infections (CC81, CC193, CC199, CC230, and CC320), all
of which were found in our study [17]. Genotype
characterization by PFGE and MLST showed that the
increase of serotype 19A invasive infections since 2002 in
both cities was mainly due to the spread of the multidrug-
resistant CC230 and the susceptible CC199 and ST1201
isolates. Although they existed before the PCV7, after its
introduction, their number increased remarkably.
The two most prevalent CCs from the USA during the
2005–2007 period were CC320 and CC199 [13]. Although,
in that country, serotype 19A IPD incidence increased
slightly during the 2005–2008 period, CC199 not only did
not increase, but it appeared to be gradually declining [13].
In the present series, CC199 was absent before 1998 and
increased over the course of the study period, due to the
spread of ST199 in San Sebastian, the only city where this
ST was found. While the frequency of ST202 significantly
decreased over the study period, ST320 emerged in the
2006–2009 period, suggesting that closely genetically
related clones can undergo distinct evolutionary events in
a specific region. Multidrug-resistant ST320 infections
increased in the USA [7, 8, 13] and Korea [4], probably
related to the additional survival advantage conferred by
antibiotic resistance. Although antimicrobial resistance has
been considered to be an advantage in clonal spread due to
selection, ST199 isolates from the present and from other
studies [7, 9, 10] were antimicrobial-susceptible, suggesting
that other factors may be responsible for the successful
spread of this clone.
The most frequent STwas the multidrug-resistant ST276
(CC230), which is a single-locus variant of the Denmark14-
ST230 clone. The ST276 clone, only present in San
Sebastian before 2001, was successfully disseminated from
2002 in both cities and was the main contributor to the
overall increase of serotype 19A infections. This multidrug-
resistant clone was also found as a frequent clone in other
studies of serotype 19A carried out in Spain [10, 11],
Portugal [12], and France [9], but, until recently, has rarely
been found in the USA [7, 8, 13].
The antimicrobial-susceptible ST1201 was the second
most frequent ST, which was present in both cities before
the introduction of the PCV7 vaccine. The incidence of
ST1201 markedly increased in Barcelona from 2006–
2009, when 15 ST1201 isolates were collected, making
ST1201 the most prevalent ST during this period. In a
recent study, ST1201 was also the most prevalent ST
found among invasive serotype 19A infections in children
in Spain [11].
ST81, related to the well-known multidrug-resistant
Spain23F-ST81 clone, was found exclusively in Barcelona.
This clone was sporadically isolated throughout the study
period. ST2013, although a common CC230 ST, was only
detected in Barcelona from children aged <5 years [10].
The most predominant STs in this study shared different
serotypes in other series, but, to our knowledge, ST202 and
ST276 isolates were exclusively associated with serotype
19A. These differences in the number of distinct serotypes
within each ST probably reflect different transformation
capabilities allowing for capsular switching.
Adult IPD due to serotype 19A S. pneumoniae has
increased in San Sebastian and Barcelona. Although serotype
19A pneumococci were genetically heterogeneous, the
increase in disease was associated with both the expansion
of existing clones and the emergence of new clones.
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